BioTuesdays

Verano names Richard Tarapchak as CFO

Verano Holdings (Cboe CA:VRNO; OTCQX:VRNOF) announced that it has promoted Richard Tarapchak to chief financial officer (CFO), succeeding Brett Summerer, who has resigned. Mr. Tarapchak brings more than 30 years of...

Brian Donnelly joins Myriad as CCO

Myriad Genetics (NASDAQ:MYGN) announced it has appointed Brian Donnelly as chief commercial officer (CCO), effective May 1, 2025. Mr. Donnelly brings more than 20 years of leadership experience in healthcare...

Telo Genomics Logo

Telo appoints John Farlinger to BOD

Telo Genomics (TSXV:TELO) announced the appointment of John Farlinger to its board of directors (BOD) and will serve as chair of the company’s audit committee. With more than 30 years of experience in telecom...

ReAlta Logo

Laurie Glimcher joins ReAlta’s BOD

Closely held ReAlta Life Sciences has appointed immunologist Laurie Glimcher, MD, to its board of directors (BOD), effective immediately. Dr. Glimcher, widely renown for her work in cancer research, brings more than 35...

Terns Pharmaceuticals

Andrew Gengos joins Terns as CFO

Terns Pharmaceuticals (NASDAQ:TERN) has announced the appointment of Andrew Gengos as chief financial officer (CFO), effective immediately. Mr. Gengos brings 25 years of leadership experience in life sciences and...

Tonix Logo

Tonix names Siobhan Fogarty as CTO

Tonix Pharmaceuticals (NASDAQ:TNXP) has announced the appointment of Siobhan Fogarty as chief technical officer (CTO), effective immediately. Previously serving as executive vice president of product development at...

Biodexa Pharmaceuticals Logo

Biodexa names Dr. Gary A. Shangold as CMO

Biodexa Pharmaceuticals (NASDAQ:BDRX) has announced the appointment of Dr. Gary A. Shangold as chief medical officer (CMO), effective immediately. The company stated that Dr. Shangold brings extensive experience across...

Eterna Therapeutics Logo

Dr. Elena Ratner joins Eterna’s BOD

Eterna Therapeutics (NASDAQ:ERNA) has announced the appointment of Elena Ratner, MD, MBA, to its board of directors. The company states that Dr. Ratner will spearhead the strategic direction of Eterna’s efforts to...

Avalo Therapeutics Logo

Avalo names Jennifer Riley as CSO

Avalo Therapeutics (NASDAQ: AVTX) has announced the appointment of Jennifer Riley as chief strategy officer (CSO), a newly created role effective January 1, 2025. Ms. Riley will oversee corporate strategy, as well as...